PKCε regulates Rho GTPases and actin cytoskeleton reorganization in non-small cell lung cancer cells

References

• Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer. 2007;7(4):281–294.
   PubMed Web of Science ®Google Scholar
• Isakov N. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Semin Cancer Biol. 2018;48:36–52.
   PubMed Web of Science ®Google Scholar
• Wu-Zhang AX, Newton AC. Protein kinase C pharmacology: refining the toolbox. Biochem J. 2013;452(2):195–209.
   PubMedGoogle Scholar
• Garg R, Benedetti LG, Abera MB, et al. Protein kinase C and cancer: what we know and what we do not. Oncogene. 2014;33(45):5225–5237.
   PubMed Web of Science ®Google Scholar
• Toton E, Ignatowicz E, Skrzeczkowska K, et al. Protein kinase cepsilon as a cancer marker and target for anticancer therapy. Pharmacol Rep. 2011;63(1):19–29.
   PubMed Web of Science ®Google Scholar
• Mischak H, Goodnight JA, Kolch W, et al. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem. 1993;268(9):6090–6096.
   PubMed Web of Science ®Google Scholar
• Perletti GP, Concari P, Brusaferri S, et al. Protein kinase cepsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway. Oncogene. 1998;16(25):3345–3348.
   PubMed Web of Science ®Google Scholar
• Bae KM, Wang H, Jiang G, et al. Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner. Cancer Res. 2007;67(13):6053–6063.
   PubMed Web of Science ®Google Scholar
• Pan Q, Bao LW, Kleer CG, et al. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res. 2005;65(18):8366–8371.
   PubMed Web of Science ®Google Scholar
• Garg R, Blando JM, Perez CJ, et al. Protein kinase C epsilon cooperates with PTEN loss for prostate tumorigenesis through the CXCL13-CXCR5 pathway. Cell Rep. 2017;19(2):375–388.
   PubMed Web of Science ®Google Scholar
• Garg R, Blando J, Perez CJ, et al. Activation of nuclear factor kappaB (NF-kappaB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon). J Biol Chem. 2012;287(44):37570–37582.
   PubMed Web of Science ®Google Scholar
• Garg R, Blando JM, Perez CJ, et al. COX-2 mediates pro-tumorigenic effects of PKCepsilon in prostate cancer. Oncogene. 2018;37:4735–4749.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Uzquiza A, Lopez-Haber C, Jernigan DL, et al. PKCepsilon is an essential mediator of prostate cancer bone metastasis. Mol Cancer Res. 2015;13(9):1336–1346.
   PubMed Web of Science ®Google Scholar
• Pan Q, Bao LW, Teknos TN, et al. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res. 2006;66(19):9379–9384.
   PubMed Web of Science ®Google Scholar
• Caino MC, Lopez-Haber C, Kissil JL, et al. Non-small cell lung carcinoma cell motility, rac activation and metastatic dissemination are mediated by protein kinase C epsilon. PloS One. 2012;7(2):e31714.
   PubMed Web of Science ®Google Scholar
• Cooke M, Zhou X, Casado-Medrano V, et al. Characterization of AJH-836, a DAG-lactone with selectivity for novel PKC isozymes. J Biol Chem. 2018;293:8330–8341.
   PubMed Web of Science ®Google Scholar
• Marei H, Malliri A. GEFs: dual regulation of Rac1 signaling. Small GTPases. 2017;8(2):90–99.
   PubMedGoogle Scholar
• Reckel S, Gehin C, Tardivon D, et al. Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase. Nat Commun. 2017;8(1):2101.
   PubMedGoogle Scholar
• Campa CC, Ciraolo E, Ghigo A, et al. Crossroads of PI3K and Rac pathways. Small GTPases. 2015;6(2):71–80.
   PubMedGoogle Scholar
• Lawson CD, Ridley AJ. Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 2018;217(2):447–457.
   PubMed Web of Science ®Google Scholar
• Zhu G, Zhang Y, Wang Q, et al. The prognostic value of Tiam1 correlates with its roles in epithelial-mesenchymal transition progression and angiogenesis in lung adenocarcinoma. Cancer Manag Res. 2019;11:1741–1752.
   PubMed Web of Science ®Google Scholar
• Baker MJ, Cooke M, Kazanietz MG. Nuclear PKCiota-ECT2-Rac1 and ribosome biogenesis: a novel axis in lung tumorigenesis. Cancer Cell. 2017;31(2):167–169.
   PubMed Web of Science ®Google Scholar
• Justilien V, Ali SA, Jamieson L, et al. Ect2-dependent rRNA synthesis is required for KRAS-TRP53-driven lung adenocarcinoma. Cancer Cell. 2017;31(2):256–269.
   PubMed Web of Science ®Google Scholar
• Havel LS, Kline ER, Salgueiro AM, et al. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene. 2015;34(15):1979–1990.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–1428.
   PubMed Web of Science ®Google Scholar
• Stemmler MP, Eccles RL, Brabletz S, et al. Non-redundant functions of EMT transcription factors. Nat Cell Biol. 2019;21(1):102–112.
   PubMed Web of Science ®Google Scholar
• Pham TND, Perez White BE, Zhao H, et al. Protein kinase C alpha enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin. BMC Cancer. 2017;17(1):832.
   PubMedGoogle Scholar
• Abera MB, Kazanietz MG. Protein kinase Calpha mediates erlotinib resistance in lung cancer cells. Mol Pharmacol. 2015;87(5):832–841.
   PubMed Web of Science ®Google Scholar
• Ouelaa-Benslama R, De Wever O, Hendrix A, et al. Identification of a GalphaGbetagamma, AKT and PKCalpha signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition. Int J Oncol. 2012;41(1):189–200.
   PubMed Web of Science ®Google Scholar
• Ghoul A, Serova M, Astorgues-Xerri L, et al. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells. Cancer Res. 2009;69(10):4260–4269.
   PubMed Web of Science ®Google Scholar
• Gandellini P, Folini M, Longoni N, et al. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res. 2009;69(6):2287–2295.
   PubMed Web of Science ®Google Scholar
• Jain K, Basu A. Protein kinase C-epsilon promotes EMT in breast cancer. Breast Cancer. 2014;8:61–67.
   PubMedGoogle Scholar
• Casado-Medrano V, Barrio-Real L, Wang A, et al. Distinctive requirement of PKCepsilon in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells. Oncogene. 2019;38:5396–5412.
   PubMed Web of Science ®Google Scholar
• Brown KA, Aakre ME, Gorska AE, et al. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. BCR. 2004;6(3):R215–31.
   PubMed Web of Science ®Google Scholar
• Yu JR, Tai Y, Jin Y, et al. TGF-beta/smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis. Genes Dev. 2015;29(3):250–261.
   PubMed Web of Science ®Google Scholar
• Burridge K, Guilluy C. Focal adhesions, stress fibers and mechanical tension. Exp Cell Res. 2016;343(1):14–20.
   PubMed Web of Science ®Google Scholar
• Chrzanowska-Wodnicka M, Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol. 1996;133(6):1403–1415.
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70(3):389–399.
   PubMed Web of Science ®Google Scholar
• Shamah SM, Lin MZ, Goldberg JL, et al. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell. 2001;105(2):233–244.
   PubMed Web of Science ®Google Scholar
• Blangy A, Vignal E, Schmidt S, et al. TrioGEF1 controls Rac- and Cdc42-dependent cell structures through the direct activation of rhoG. J Cell Sci. 2000;113(Pt 4):729–739.
   PubMed Web of Science ®Google Scholar
• Abe K, Rossman KL, Liu B, et al. Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem. 2000;275(14):10141–10149.
   PubMed Web of Science ®Google Scholar
• Holinstat M, Mehta D, Kozasa T, et al. Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. J Biol Chem. 2003;278(31):28793–28798.
   PubMed Web of Science ®Google Scholar
• Jiang W, Betson M, Mulloy R, et al. p190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration. J Biol Chem. 2008;283(30):20978–20988.
   PubMed Web of Science ®Google Scholar
• Levay M, Settleman J, Ligeti E. Regulation of the substrate preference of p190RhoGAP by protein kinase C-mediated phosphorylation of a phospholipid binding site. Biochemistry. 2009;48(36):8615–8623.
   PubMed Web of Science ®Google Scholar
• Tripathi BK, Grant T, Qian X, et al. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1. J Cell Biol. 2017;216(12):4255–4270.
   PubMed Web of Science ®Google Scholar
• Olson MF. Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors. Small GTPases. 2018;9(3):203–215.
   PubMedGoogle Scholar
• Lang P, Gesbert F, Delespine-Carmagnat M, et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 1996;15(3):510–519.
   PubMed Web of Science ®Google Scholar
• Su T, Straight S, Bao L, et al. PKC epsilon phosphorylates and mediates the cell membrane localization of RhoA. ISRN Oncol. 2013;2013:329063.
   PubMedGoogle Scholar
• Kato K, Yazawa T, Taki K, et al. The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration. Mol Biol Cell. 2012;23(13):2593–2604.
   PubMed Web of Science ®Google Scholar
• Asanuma K, Yanagida-Asanuma E, Faul C, et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol. 2006;8(5):485–491.
   PubMed Web of Science ®Google Scholar
• Jacob T, Van den Broeke C, Van Waesberghe C, et al. Pseudorabies virus US3 triggers RhoA phosphorylation to reorganize the actin cytoskeleton. J Gen Virol. 2015;96(8):2328–2335.
   PubMedGoogle Scholar
• Zhu H, Kavsak P, Abdollah S, et al. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 1999;400(6745):687–693.
   PubMed Web of Science ®Google Scholar
• Liu WT, Huang KY, Lu MC, et al. TGF-beta upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability. Oncogene. 2017;36(19):2715–2723.
   PubMed Web of Science ®Google Scholar
• Qu MH, Han C, Srivastava AK, et al. miR-93 promotes TGF-beta-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumour Biol. 2016;37(4):5645–5651.
   PubMedGoogle Scholar
• Payapilly A, Malliri A. Compartmentalisation of RAC1 signalling. Curr Opin Cell Biol. 2018;54:50–56.
   PubMed Web of Science ®Google Scholar